Sierra Oncology, Inc.

SRRACIK 0001290149 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0017

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Sierra Oncology, Inc.

Name	Roles	Filings
Turner William D.	Officer	7
Thomson Mary Christina	Officer	6
Dilly Stephen George	OfficerDirector	3
Enright Patrick G	10% Owner	3
Jagpal Sukhi	Officer	3

Showing 1-5 of 29

Per pagePage 1 of 6Next

All filings

39 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 17, 2022	Thomson Mary Christina General Counsel, CCO & Sec'y	Holdings only	-	-	-
Jun 17, 2022	Dilly Stephen George CEO and President · Director	Holdings only	-	-	-
Jun 17, 2022	Jagpal Sukhi Chief Financial Officer	Holdings only	-	-	-
Jun 17, 2022	Klencke Barbara Chief Medical Officer	Holdings only	-	-	-
Jun 17, 2022	Norrett Kevin Chief Business Officer	Holdings only	-	-	-

Showing 1-5 of 39

Per pagePage 1 of 8Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value